Structure and receptor activity for classical cannabinoids

Current Medicinal Chemistry

Volumn 6, Issue 8, 1999, Pages 685-704

  Seltzman, H H ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABIDIOL; CANNABINOID RECEPTOR; CANNABIS; DEXANABINOL; DRONABINOL; HU 243; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; BINDING AFFINITY; CANNABIS ADDICTION; DRUG CONFORMATION; HYDROGEN BOND; LIGAND BINDING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN INTERACTION; RAT; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; CANNABINOIDS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032792925     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Mechoulam, R., Ed. In Cannabinoids as Therapeutic Agents; CRC Press: Boca Raton, FL, 1986.
2. ACM Association for Cannabis as Medicine Internet Web Site http://www.acmed.org/english/index.html
3. Gaoni, Y.; Mechoulam, R. Journal of the American Chemical Society, 1964, 86, 1646.
4. Mechoulam, R.; Shani, A.; Ederly, H.; Grunfeld, Y. Science (Washington, D. C., 1883-), 1970, 169, 611.
5. Hollister, L.E. Pharmacol. Rev., 1986, 38, 1.
6. Dewey, W.L. Pharmac. Rev., 1986, 38, 151.
7. Martin, B.R. Pharmac. Rev., 1986, 38, 45.
8. Razdan, R.K. Pharmac. Rev., 1986, 38, 75.
9. Makriyannis, A.; Rapaka, R.S. Life Sciences, 1990, 47, 2173.
10. Mechoulam, R.; Devane, W.A.; Glaser, R. In Marijuana/Cannabinoids: Neurobiology and Neurophysiology, Murphy, L.; Bartke, A., Eds.; CRC Press, Boca Raton, 1992, p 1.
11. Musty, R.E.; Reggio, P.; Consroe, P. Life Sci, 1995, 56, 1933.
12. Johnson, M.R.; Melvin, L.S. Cannabinoids as Therapeutic Agents, CRC Press, Boca Raton, FL, 1986, 121.
13. Mechoulam, R.; Feigenbaum, J.J.; Lander, N.; Segal, M.; Jarbe, T.U.; Hiltunen, A.J.; Consroe, P. Experientia, 1988, 44, 762.
14. Mechoulam, R.; Lander, N.; Srebnik, M.; Breuer, A.; Segal, M.; Feigenbaum, J.J.; Jarbe, T.U.; Consroe, P. NIDA Res Monogr, 1987, 79, 15.
15. Devane, W.A.; Dysarz, F.A.; Johnson, M.R.; Melvin, L.S.; Howlett, A.C. Mol. Pharmacol., 1988, 34, 605.
16. Herkenham, M.; Lynn, A.B.; Johnson, M.R.; Melvin, L.S.; De Costa, B.R.; Rice, K.C. J. Neurosci., 1991, 11, 563.
17. Herkenham, M.; Lynn, A.B.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; de Costa, B.R.; Rice, K.C. Proc Natl Acad Sci U S A, 1990, 87, 1932.
18. Johnson, M.R.; Rice, K.C.; Howlett, A.; Melvin, L.S.; Herkenham, M. NIDA Res Monogr, 1992, 119, 86.
19. Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Nature (London), 1990, 346, 561.
20. Compton, D.R.; Rice, K.C.; De Costa, B.R.; Razdan, R.K.; Melvin, L.S.; Johnson, M.R.; Martin, B.R. J Pharmacol Exp Ther, 1993, 265, 218.
21. Munro, S.; Thomas, K.L.; Abu-Shaar, M. Nature (London), 1993, 365, 61.
22. Edery, H.; Grunfeld, Y.; Porath, G.; Ben-Zvi, Z.; Shani, A.; Mechoulam, R. Arzneim.-Forsch/Drug Res., 1972, 22, 1995.
23. Melvin, L.S.; Milne, G.M.; Johnson, M.R.; Subramaniam, B.; Wilken, G.H.; Howlett, A.C. Mol Pharmacol, 1993, 44, 1008.
24. Melvin, L.S.; Milne, G.M.; Johnson, M.R.; Wilken, G.H.; Howlett, A.C. Drug Des Discov, 1995, 13, 155.
25. Howlett, A.C.; Johnson, M.R.; Melvin, L.S.; Milne, G.M. Molecular Pharmacology, 1988, 33, 297.
26. Martin, B.R.; Compton, D.R.; Prescott, W.R.; Barrett, R.L.; Razdan, R.K. Drug Alcohol Depend, 1995, 37, 231.
27. Adams, R.; Mackenzie, S.J.; Loewe, S. J. Am. Chem. Soc., 1948, 70, 664.
28. Adams, R. Harvey Lectures, 1942 February 19, 1942
29. Devane, W.A.; Breuer, A.; Sheskin, T.; Jarbe, T.U.C.; Eisen, M.S.; Mechoulam, R. J. Med. Chem., 1992, 35, 2065.
30. Guo, Y.; Abadji, V.; Morse, K.L.; Fournier, D.J.; Li, X.; Makriyannis, A. J Med Chem, 1994, 37, 3867.
31. Tius, M.A.; Hill, W.A.G.; Zou, X.L.; Busch-Petersen, J.; Kawakami, J.K.; Fernandez-Garcia, M.C.; Drake, D.J.; Abadji, V.; Makriyannis, A. Life Sci., 1995, 56, 2007.
32. Huffman, J.W.; Yu, S.; Showalter, V.; Abood, M.E.; Wiley, J.L.; Compton, D.R.; Martin, B.R.; Bramblett, R.D.; Reggio, P.H. J. Med. Chem., 1996, 39, 3875.
33. Huffman, J.W.; Lainton, J.A.; Dai, D.; Jordan, R.D.; Duncan, S.G., Jr. Life Sci, 1995, 56, 2021.
34. Huffman, J.W.; Lainton, J.A.H.; Banner, W.K.; Duncan, J., S. G.; Jordan, R.D.; Yu, S.; Dai, D.; Martin, B.R.; Wiley, J.L.; Compton, D.R. Tetrahedron, 1997, 53, 1557.
35. Adams, R.; Aycock, B.F.; Loewe, S. Journal of the American Chemical Society, 1948, 70, 662.
36. Huffman, J.W.; Duncan, S.G.; Wiley, J.L.; Martin, B.R. Bioorganic & Med. Chem. Lett., 1997, 7, 2799.
37. Liddle, J.; Huffman, J.W.; Wiley, J.L.; Martin, B.R. Bioorg Med Chem Lett, 1998, 8, 2223.
38. Papahatjis, D.P.; Kourouli, T.; Abadji, V.; Goutopoulos, A.; Makriyannis, A. J Med Chem, 1998, 41, 1195.
39. Mavromoustakos, T.; Theodoropoulou, E.; Zervou, M.; Kourouli, T.; Papahatjis, D. J Pharm Biomed Anal, 1999, 18, 947.
40. Charalambous, A.; Lin, S.; Marciniak, G.; Banijamali, A.; Friend, F.L.; Compton, D.R.; Martin, B.R.; Makriyannis, A. Pharmacol Biochem Behav, 1991, 40, 509.
41. Martin, B.R.; Compton, D.R.; Semus, S.F.; Lin, S.; Marciniak, G.; Grzybowska, J.; Charalambous, A.; Makriyannis, A. Pharmacol Biochem Behav, 1993, 46, 295.
42. Singer, M.; Ryan, W.J.; Saha, B.; Martin, B.R.; Razdan, R.K. J Med Chem, 1998, 41, 4400.
43. Seltzman, H.H.; Setzer, S.R.; Williams, D.L.; Demian, I.; Wyrick, C.; Pitt, C.G. In Marihuana '84, Proceedings of the Oxford Symposium on Cannabis; Harvey, D.J., Ed.; IRL Press: Oxford & Washington DC, 1985, p 183.
44. Nye, J.S.; Seltzman, H.H.; Pitt, C.G.; Snyder, S.H. J Pharmacol Exp Ther, 1985, 234, 784.
45. Nye, J.S.; Snowman, A.M.; Voglmaier, S.; Snyder, S.H. J. Neurochem., 1989, 52, 1892.
46. Compton, D.R.; Martin, B.R. Life Sci, 1990, 46, 1575.
47. Charalambous, A.; Yan, G.; Houston, D.B.; Howlett, A.C.; Compton, D.R.; Martin, B.R.; Makriyannis, A. J Med Chem, 1992, 35, 3076.
48. Busch-Petersen, J.; Hill, W.A.; Fan, P.; Khanolkar, A.; Xie, X.Q.; Tius, M.A.; Makriyannis, A. J Med Chem, 1996, 39, 3790.
49. Xie, X.Q.; Yang, D.P.; Melvin, L.S.; Makriyannis, A. J Med Chem, 1994, 37, 1418.
50. Ryan, W.; Singer, M.; Razdan, R.K.; Compton, D.R.; Martin, B.R. Life Sci, 1995, 56, 2013.
51. Ross, R.A.; Brockie, H.C.; Fernando, S.R.; Saha, B.; Razdan, R.K.; Pertwee, R.G. Br J Pharmacol, 1998, 125, 1345.
52. Pertwee, R.G.; Fernando, S.R.; Griffin, G.; Ryan, W.; Razdan, R.K.; Compton, D.R.; Martin, B.R. Eur J Pharmacol, 1996, 315, 195.
53. Huffman, J.W.; Yu, S. Bioorg Med Chem, 1998, 6, 2281.
54. Lu, D.; Khanolkar, A.; Meng, Z.; Fan, P.; Reggio, P.H.; Makriyannis, A. Presented at: International Cannabinoid Research Society, 1997 Symposium on the Cannabinoids, Stone Mountain, Georgia, ICRS, p 1(1997).
55. Martin, B.R.; Kallman, M.J.; Kaempf, G.F.; Harris, L.S.; Dewey, W.L.; Razdan, R.K. Pharmacol., Biochem. Behav., 1984, 21, 61.
56. Little, P.J.; Compton, D.R.; Mechoulam, R.; Martin, B.R. Pharmacol Biochem Behav, 1989, 32, 661.
57. Wilson, R.S.; May, E.L.; Martin, B.R.; Dewey, W.L. J. Med. Chem., 1976, 19, 1165.
58. Archer, R.A.; Stark, P.; Lemberger, L. In Cannabinoids as therapeutic agents; Mechoulam, R., Ed.; CRC Press: Boca Raton, FL, 1986, Chapter 5, p 85.
59. Thomas, B.F.; Compton, D.R.; Martin, B.R.; Semus, S.F. Mol Pharmacol, 1991, 40, 656.
60. Reggio, P.H.; Greer, K.V.; Cox, S.M. J. Med. Chem., 1989, 32, 1630.
61. Martin, B.R.; Dewey, W.L.; Harris, L.S.; Beckner, J.; Wilson, R.S.; May, E.L. Pharmacol., Biochem. Behav., 1975, 3, 849.
62. Kriwacki, R.W.; Makriyannis, A. Mol. Pharmacol., 1989, 35, 495.
63. Reggio, P.H.; Panu, A.M.; Miles, S. J. Med. Chem., 1993, 36, 1761.
64. Mechoulam, R.; Breuer, A.; Jarbe, T.U.; Hiltunen, A.J.; Glaser, R. J Med Chem, 1990, 33, 1037.
65. Reggio, P.H.; Bramblett, R.D.; Yuknavich, H.; Seltzman, H.H.; Fleming, D.N.; Fernando, S.R.; Stevenson, L.A.; Pertwee, R.G. Life Sci, 1995, 56, 2025.
66. Reggio, P.H.; McGaughey, G.B.; Odear, D.F.; Seltzman, H.H.; Compton, D.R.; Martin, B.R. Pharmacol., Biochem. Behav., 1991, 40, 479.
67. Uliss, D.B.; Dalzell, H.D.; Handrick, G.R.; Howes, J.F.; Razdan, R.K. J. Med. Chem., 1975, 18, 213.
68. Razdan, R.K. NIDA Res Monogr, 1987, 79, 3.
69. Martin, B.R.; Harris, L.S.; Dewey, W.L. In The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects; Agurell, S.; Dewey, W.L. ; Willette, R.E., Eds.; Academic Press: Orlando, FL, 1984, p 523.
70. Compton, D.R.; Prescott, W.R., Jr.; Martin, B.R.; Siegel, C.; Gordon, P.M.; Razdan, R.K. J. Med. Chem., 1991, 34, 3310.
71. Zitko, B.A.; Howes, J.F.; Razdan, R.K.; Dalzell, B.C.; Dalzell, H.C.; Sheehan, J.C.; Pars, H.G. Science, 1972, 177, 442.
72. McIlhenny, H.M.; Mast, R.W.; Johnson, M.R.; Milne, G.M. Journal of Pharmacology and Experimental Therapeutics, 1981, 219.
73. Binder, M.; Franke, I., Eds. In Is there a THC Receptor?; Walter de Guyter: New York, 1982; , p 151.
74. Reggio, P.H.; Mazurek, A.P. J. Mol. Struct., 1987, 149.
75. a) Semus, S.F.; Martin, B.R. Life Sciences, 1990, 46, 1781;
76. b) Semus, S. F. Med. Chem. Res., 1992, 1, 454
77. Reggio, P.H. In Structure-Activity Relationships of the Cannnabinoids, NIDA Monograph 79; Makriyannis, R.S.R.a.A., Ed.; NIDA, 1987; Vol. 79, Structure-Activity Relationships of the Cannnabinoids, NIDA Monograph 79, p 82.
78. Reggio, P.H.; Seltzman, H.H.; Compton, D.R.; Prescott, W.R., Jr.; Martin, B.R. Mol Pharmacol, 1990, 38, 854.
79. Seltzman, H.H.; Hsieh, Y.A.; Pitt, C.G.; Reggio, P.H. J. Org. Chem., 1991, 56, 1549.
80. Reggio, P.H.; Wang, T.; Brown, A.E.; Fleming, D.N.; Seltzman, H.H.; Griffin, G.; Pertwee, R.G.; Compton, D.R.; Abood, M.E.; Martin, B.R. J. Med. Chem., 1997, 40, 3312.
81. Tius, M.A.; Kawakami, J.K.; Hill, W.A.G.; Makriyannis, A. Chem. Commun. (Cambridge), 1996, 2085.
82. Birchall, J.M.; Haszeldine, R.N. J. Chem. Soc., 1959, 1959, 3653.
83. Gareau, Y.; Dufresne, C.; Gallant, M.; Rochette, C.; Sawyer, N.; Slipetz, D.M.; Tremblay, N.; Weech, P.K.; Metters, K.M.; Labelle, M. Bioorg. Med. Chem. Lett., 1996, 6, 189.
84. Song, Z.H.; Bonner, T.I. Mol Pharmacol, 1996, 49, 891.
85. Melvin, L.S.; Johnson, M.R. In Structure-Activity Relationships of the Cannabinoids; Makriyannis, R.S.R.a.A., Ed.; NIDA, 1987, Structure-Activity Relationships of the Cannabinoids, NIDA Monograph 79.
86. Melvin, L.S.; Johnson, M.R.; Harbert, C.A.; Milne, G.M.; Weissman, A. J. Med. Chem., 1984, 27, 67.
87. Little, P.J.; Compton, D.R.; Johnson, M.R.; Melvin, L.S.; Martin, B.R. J Pharmacol Exp Ther, 1988, 247, 1046.
88. Yan, G.; Yin, D.; Khanolkar, A.D.; Compton, D.R.; Martin, B.R.; Makriyannis, A. J. Med. Chem., 1994, 37, 2619.
89. Tius, M.A.; Makriyannis, A.; Zou, X.L.; Abadji, V. Tetrahedron, 1994, 50, 2671.
90. Drake, D.J.; Jensen, R.S.; Busch-Petersen, J.; Kawakami, J.K.; Concepcion Fernandez-Garcia, M.; Fan, P.; Makriyannis, A.; Tius, M.A. J Med Chem, 1998, 41, 3596.
91. Felder, C.C.; Joyce, K.E.; Briley, E.M.; Mansouri, J.; Mackie, K.; Blond, O.; Lai, Y.; Ma, A.L.; Mitchell, R.L. Mol Pharmacol, 1995, 48, 443.
92. Showalter, V.M.; Compton, D.R.; Martin, B.R.; Abood, M.E. J Pharmacol Exp Ther, 1996, 278, 989.
93. Bramblett, R.D.; Panu, A.M.; Ballesteros, J.A.; Reggio, P.H. Life Sci, 1995, 56, 1971.